Pleryon Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $15.7M

  • Investors
  • 3

Pleryon Therapeutics General Information

Description

Developer of drug delivery system designed for new drug discovery. The company's drug delivery technology covers a broad spectrum of molecules and therapeutic areas, enabling patients to have innovative new drugs for treatment.

Contact Information

Website
www.pleryon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, Unit 3B, DBH Life Science Technology Park
  • 2028 Shenyan Road, Yantian
  • Shenzhen, Guangdong
  • China
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Delivery
Corporate Office
  • 6th Floor, Unit 3B, DBH Life Science Technology Park
  • 2028 Shenyan Road, Yantian
  • Shenzhen, Guangdong
  • China

Pleryon Therapeutics Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pleryon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Apr-2022 $15.7M Completed Generating Revenue
1. Early Stage VC 21-Dec-2020 Completed Generating Revenue
To view Pleryon Therapeutics’s complete valuation and funding history, request access »

Pleryon Therapeutics Executive Team (1)

Name Title Board Seat
Yu Yu Ph.D Co-Founder, Chairman & Chief Executive Officer
To view Pleryon Therapeutics’s complete executive team members history, request access »

Pleryon Therapeutics Board Members (1)

Name Representing Role Since
Yu Yu Ph.D Pleryon Therapeutics Co-Founder, Chairman & Chief Executive Officer
To view Pleryon Therapeutics’s complete board members history, request access »

Pleryon Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kaitai Capital Venture Capital Minority
Lapam Capital Venture Capital Minority
Zero2IPO Venture Capital Corporate Venture Capital Minority
To view Pleryon Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Pleryon Therapeutics FAQs

  • When was Pleryon Therapeutics founded?

    Pleryon Therapeutics was founded in 2016.

  • Who is the founder of Pleryon Therapeutics?

    Yu Yu Ph.D is the founder of Pleryon Therapeutics.

  • Who is the CEO of Pleryon Therapeutics?

    Yu Yu Ph.D is the CEO of Pleryon Therapeutics.

  • Where is Pleryon Therapeutics headquartered?

    Pleryon Therapeutics is headquartered in Shenzhen, China.

  • What industry is Pleryon Therapeutics in?

    Pleryon Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Pleryon Therapeutics a private or public company?

    Pleryon Therapeutics is a Private company.

  • What is Pleryon Therapeutics’s current revenue?

    The current revenue for Pleryon Therapeutics is .

  • How much funding has Pleryon Therapeutics raised over time?

    Pleryon Therapeutics has raised $15.7M.

  • Who are Pleryon Therapeutics’s investors?

    Kaitai Capital, Lapam Capital, and Zero2IPO Venture Capital have invested in Pleryon Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »